Chronic Joint Disease ( Djd )

1740 Words7 Pages
According to Petterson and Jacobsson (2002), degenerative joint disease (DJD) or osteoarthritis is the most common joint disorder seen in humans, affecting 60% of adults 60 years of age and older. Many studies have attempted to treat patients with DJD in a number of different ways including the use of the drug glucosamine, glucosamine and alendronate. Hamid Reza Arti and Mohammad Ebrahim Azemi undertook their own research in 2012 by comparing the effect of glucosamine and glucosamine with alendronate in symptomatic relieve of degenerative knee joint disease. They believed that due to the high prevalence of osteoarthritis especially knee osteoarthritis identification of effective treatment methods was an important factor in medical treatment of knee osteoarthritis. According to Arti and Azemi (2012) no previous study had addressed these issues. The nature of their study was a prospective double blind randomized clinical trial study. Double blind studies are ‘experiments designed to test the effect of a treatment or substance by using groups of experimental and control subjects in which neither the subjects nor the investigators know which treatment or substance is being administered to which group’ (Farlex Partner Medical Dictionary, 2008). The aim of the study was to compare the effects of glucosamine alone and combination of glucosamine and alendronate administration to treat knee osteoarthritis. Arti and Azemi aimed to test the hypothesis that combination
Open Document